No Data
No Data
It's Time for Investors to Rotate, With Opportunities Down the Market Cap – Piper Sandler
A Quick Look at Today's Ratings for Leap Therapeutics(LPTX.US), With a Forecast Between $1.25 to $3
Sector Update: Health Care Stocks Decline Late Afternoon
This Apple Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
H.C. Wainwright Downgrades Leap Therapeutics(LPTX.US) to Hold Rating
Piper Sandler Maintains Leap Therapeutics(LPTX.US) With Buy Rating, Cuts Target Price to $3